posted
Just kidding with you Davo, just have to be patient a little bit longer, somethings bound to happen soon, it's been a while since we heard any substantial news from them, and that financing has got to be getting close to finalized.
IP: Logged |
posted
Company spokesperson eluded to possible news release soon. Volume has been decent. Pretty narrow range last few. Wouldn't take much to push this back up into 8's or 9's .... imho
-------------------- " Cash is King "
IP: Logged |
posted
Press Release Source: Advanced Plant Pharmaceuticals, Inc.
Advanced Plant Pharmaceuticals Announces Director and CTO of World Health Energy ("WHE"), Edwin Zhao, to Attend National Biodiesel Conference & Expo 2007 From February 4-7 in San Antonio, Texas Wednesday January 31, 9:45 am ET
NEW YORK, Jan. 31, 2007 (PRIME NEWSWIRE) -- Advanced Plant Pharmaceuticals, Inc. (OTC BB:APPI.OB - News) announced today that Mr. Edwin Zhao, Chief Technology Officer and Director of World Health Energy, Inc., will attend the National Biodiesel Conference and Expo 2007 http://www.biodieselconference.com/2007/default.asp. This year's National Biodiesel Conference will have a record number of biodiesel marketers, feedstock growers, fuel distributors, government leaders and biodiesel users attending the three day conference. The National Biodiesel Board is conducting a comprehensive educational program featuring presentations and discussions from the foremost authorities and participants in the rapidly expanding biodiesel industry. Federal and State tax incentives for alternative fuel producers including grants, tax exemptions and tax credits are part of the seminar schedule.
Edwin Zhao, has 30 years of experience in the energy sector and developed WHE's alternative energy business model. From 1983 - 1991 Mr. Zhao was a key member of the team that installed the world's largest supervisory control system in Syncrude Canada Limited in Fort McMurray, Alberta, Canada's largest oil company. Mr. Zhao subsequently supervised the installation and commissioning of the Honeywell TDC3000 control systems in Suncor - Fort McMurray, Esso - Cold Lake, and Shell - Peace River.
Mr. Zhao holds numerous awards -- including the Honeywell Canada-wide, Technical Achiever Award in 1988 and the Technical Design Award with Westcoast Energy Transmission, Canada's largest Natural Gas Plant. The Technical Design Award was for redesigning the CSEM (Continuous Stack Emission Monitoring) and was the largest monetary award awarded by Westcoast Energy Transmission at the time of the award. He has advised the government on energy conservation and energy reserve matters and has written several energy audit programs. He worked with the British Columbia Hydro energy division in the study and development of the ``Efficient use of Electrical Motors'' and wrote a program that was used Canada-wide for the energy audits.
World Health Energy, Inc. plans to use renewable cost-effective agricultural products both domestically and internationally to develop natural alternative fuels. The company continues to work towards a binding financing agreement for $1.2 million financing for the construction of two bio-diesel plants.
To be added to Advanced Plant Pharmaceuticals' corporate e-mail list for shareholders and interested investors, please send an e-mail to ir*advancedplantpharm.com.
About World Health Energy, Inc. (http://www.worldhealthenergy.com)
World Health Energy, Inc. is a renewable energy company focused on developing and producing alternative fuels. WHE's proposed biodiesel production plants are designed to produce biodiesel that complies to or exceeds international biodiesel production requirements and standards, including the European standard for Biodiesel EN 14214, as well as United States ASTM D6751 specifications.
About Advanced Plant Pharmaceuticals, Inc. (http://www.advancedplantpharm.com)
Advanced Plant Pharmaceuticals, Inc. (APPI) has focused on the research and development of whole plant-based nutritionals. The company has a composition-oriented patent for a proprietary process of utilizing whole plants to safely manufacture all-natural nutritional supplements. APPI markets and distributes its line of products including Lo-Chol(tm) worldwide through various sales distribution channels. The company is currently in the initial stages of shifting its business plan to enter the rapidly growing renewable energy market.
``Safe Harbor Statement'' Under The Private Securities Litigation Reform Act Of 1995
This press release contains forward-looking statements that involve risks and uncertainties. The statements in this release are forward-looking statements that are made pursuant to safe harbor provision of the Private Securities Litigation Reform Act of 1995. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. These statements involve known and unknown risks and uncertainties, which may cause Advanced Plant Pharmaceuticals, Inc.'s actual results in future periods to differ materially from results expressed or implied by forward-looking statements. These risks and uncertainties include, among other things, product demand and market competition. You should independently investigate and fully understand all risks before making investment decisions.
Contact: Advanced Plant Pharmaceuticals, Inc. Investor Relations: LC Group Rick Lutz (404) 261-1196 ir*advancedplantpharm.com
-------------------------------------------------------------------------------- Source: Advanced Plant Pharmaceuticals, Inc.
IP: Logged |
posted
Company spokesperson hinted at news soon. They have done a " Friday after the close news release " before. Would definitely be great today. Stock has been languishing ( sp?? ) as of late.
-------------------- " Cash is King "
IP: Logged |
Advanced Plant Pharmaceuticals Rated 'Speculative Buy,' Target Price $0.06 by Beacon Equity Research
Friday , February 02, 2007 16:05ET
DALLAS, Feb 02, 2007 (BUSINESS WIRE) -- Advanced Plant Pharmaceuticals (OTCBB:APPI) has been rated "Speculative Buy" with a target price of $0.06 by Beacon Equity Research Analyst Dr. Victor Sula.
Anyone interested in receiving alerts regarding Advanced Plant Pharmaceuticals research should email members*beaconequityresearch.com with "APPI" in the subject line.
In the report, Dr. Sula writes, "Advanced Plant Pharmaceuticals, Inc. is shifting its business plan to focus on biofuels and renewable energy production and distribution. In Q4FY06, APPI announced an agreement to acquire World Health Energy (WHE), a renewable energy company focused on the development and production of alternative fuels. WHE plans to use cost-effective agricultural products both locally and from around the world to develop natural alternative fuels. The Company plans to build two biodiesel plants in the US and is in the process of securing financing for their construction."
"According to Clean Edge research, the global biofuels market will grow from $15.7 billion in 2005 to $52.5 billion by 2015. Meanwhile, Emerging Markets Online forecasts US biodiesel consumption will grow to 750 million gallons by the end of 2007. Moreover, the US biodiesel market should grow significantly to match the consumption levels of European counterparts. Total biodiesel sales in the US amounted to less than 0.5% of all petro-diesel on-road consumption in 2005."
"We believe the Company's market capitalization and valuation will gravitate towards its bio-fuel peers. Many early-stage bio-fuel companies are trading at huge premiums to other industry medians. Competitors such as Earth Biofuels (OTCBB:EBOF), Pacific Ethanol (Nasdaq:PEIX), Verasun Energy (NYSE:VSE) and Southridge Ethanol (OTCBB:SORD) trade at a P/S multiple of roughly 10 or less."
Beacon Equity Research Disclosure
The analysts contributing to this report do not hold any shares of Advanced Plant Pharmaceuticals (APPI). Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. The analyst(s) writing this report recognize and aspire to all of the CFA Institute Guidelines for Independent Research. Beacon Equity Research ("Beacon") certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analysts in the report. Beacon has directly been compensated seven thousand five hundred dollars by Oceanic Consulting for enrollment in its research program. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change.
SOURCE: Advanced Plant Pharmaceuticals
Beacon Equity Research Jeff Bishop, 469-252-3035 editor*beaconequityresearch.com www.BeaconEquityResearch.com or Advanced Plant Pharmaceuticals Rick Lutz, 404-261-1196 ir*advancedplantpharm.com
Copyright Business Wire 2007
-------------------- " Cash is King "
IP: Logged |
posted
IMO we should be hearing good news any day now. Adding to my position here in the 5's, .005's will be considered very cheap in the next few days, IMO
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Mad]](mad.gif)
